Literature DB >> 3016739

Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes.

D C Gamett, S E Tracy, H L Robinson.   

Abstract

Eleven recently isolated erbB-transducing viruses as well as avian erythroblastosis virus (AEV)-R (ES4) and AEV-H have been characterized for the type of disease they cause, their ability to transform fibroblasts in culture, their ability to cause disease in pedigrees of chicken that differ in susceptibility to erbB-induced erythroblastosis, and the structure of their erbB genes. Differences in each of the biological parameters correlated with differences in erbB sequences encoding the C-terminal domain of the epidermal growth factor receptor (EGFR). Seven viruses were strain restricted in their ability to induce erythroblastosis and did not transform fibroblasts. These seven viruses contained v-erbB genes encoding the complete C terminus of the EGFR. AEV-R and AEV-H were not pedigree restricted in their ability to induce erythroblastosis and could transform fibroblasts. These viruses contain v-erbB genes that lack codons for the immediate C terminus of the EGFR. Three viruses caused angiosarcoma and one caused fibrosarcoma. The angiosarcoma and fibrosarcoma-inducing viruses were not strain restricted and did not cause erythroblastosis. The v-erbB genes of each of these viruses contained extensive internal deletions or 3' truncations in sequences encoding the C-terminal domain of the EGFR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016739      PMCID: PMC386436          DOI: 10.1073/pnas.83.16.6053

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Avian leukemia viruses: interaction with their target cells in vivo and in vitro.

Authors:  T Graf; H Beug
Journal:  Biochim Biophys Acta       Date:  1978-11-17

2.  The erbB gene of avian erythroblastosis virus is a member of the src gene family.

Authors:  T Yamamoto; T Nishida; N Miyajima; S Kawai; T Ooi; K Toyoshima
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

3.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.

Authors:  B A White; F C Bancroft
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells.

Authors:  H L Robinson
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

6.  Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes.

Authors:  L Frykberg; S Palmieri; H Beug; T Graf; M J Hayman; B Vennström
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

7.  Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity.

Authors:  L Sealy; M L Privalsky; G Moscovici; C Moscovici; J M Bishop
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

8.  Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1.

Authors:  H L Robinson; L Jensen; J M Coffin
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas.

Authors:  T Yamamoto; H Hihara; T Nishida; S Kawai; K Toyoshima
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

10.  Avian erythroblastosis virus isolated from chick erythroblastosis induced by lymphatic leukemia virus subgroup A.

Authors:  H Hihara; H Yamamoto; H Shimohira; K Arai; T Shimizu
Journal:  J Natl Cancer Inst       Date:  1983-05       Impact factor: 13.506

View more
  20 in total

1.  Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.

Authors:  S Massoglia; A Gray; T J Dull; S Munemitsu; H J Kun; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB.

Authors:  A Wells; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Functional differences between Stat3alpha and Stat3beta.

Authors:  T S Schaefer; L K Sanders; O K Park; D Nathans
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Authors:  S P Yee; D Mock; P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.

Authors:  T J Velu; W C Vass; D R Lowy; L Beguinot
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

6.  The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.

Authors:  J E Strong; P W Lee
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Induction of renal adenocarcinoma by a nonmutated erbB oncogene.

Authors:  C A Taglienti-Sian; B Banner; R J Davis; H L Robinson
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Structural alterations of the epidermal growth factor receptor gene in human gliomas.

Authors:  A J Wong; J M Ruppert; S H Bigner; C H Grzeschik; P A Humphrey; D S Bigner; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

9.  Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates.

Authors:  K Seedorf; B Millauer; G Kostka; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

10.  Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.

Authors:  L Hubler; P S Leventhal; P J Bertics
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.